Table 3 Adverse event and serious adverse event counts, percentages given in brackets, for 132 patients, who underwent total knee arthroplasty (TKA) before implementation of a critical pathway on TKA, versus 128 patients, who underwent TKA after path implementation
From: Adverse events in total knee arthroplasty: Results of a physician independent survey in 260 patients
Before pathway implementation | After pathway implementation | Total | |
|---|---|---|---|
adverse event | n = 132 | n = 128 | n = 260 |
Generalised seizure due to local anaesthetic intoxication | 0 (0) | 1 (1) | 1 (0) |
DVT (lower leg) | 10 (8) | 6 (5) | 16 (6) |
DVT (knee) | 4 (3) | 2 (2) | 6 (2) |
DVT (thigh) | 0 (0) | 1 (1) | 1 (0) |
Haematoma | 1 (1) | 3 (2) | 4 (2) |
Wound healing problems | 1 (1) | 0 (0) | 1 (0) |
Stiff knee | 0 (0) | 1 (1) | 1 (0) |
Gastrointestinal bleeding | 0 (0) | 3 (2) | 3 (1) |
Dekubital ulcer | 1 (1) | 2 (2) | 3 (1) |
Postoperative cognitive disorder | 1 (1) | 0 (0) | 1 (0) |
Speech disturbance and Hyperkinesia in Parkinson disease | 2 (2) | 1 (1) | 3 (1) |
Postoperative hypertonia | 1 (1) | 3 (2) | 4 (2) |
Cardiac blocks | 2 (2) | 2 (2) | 4 (2) |
Diarrhoea | 1 (1) | 1 (1) | 2 (1) |
Obstipation | 0 (0) | 1 (1) | 1 (0) |
Erysipel | 1 (1) | 0 (0) | 1 (0) |
Exanthema | 1 (1) | 3 (2) | 4 (2) |
Otolaryngology consultation* | 2 (2) | 0 (0) | 2 (1) |
Dentist consultation* | 1 (1) | 0 (0) | 1 (0) |
Urinary tract infection | 0 (0) | 2 (2) | 2 (1) |
Urologic consultation* | 1 (1) | 2 (2) | 3 (1) |
Fall | 0 (0) | 2 (2) | 2 (1) |
Posterior collum lesion (myelon)* | 0 (0) | 1 (1) | 1 (0) |
Hyperhomocystinemia* | 0 (0) | 1 (1) | 1 (0) |
Total AE | 30 (23) | 38 (29) | 68 (26) |
serious adverse event | |||
Death during study period, unrelated | 1 (1) | 1 (1) | 2 (1) |
Resuscitation (cardiological cause) | 1 (1) | 0 (0) | 1 (0) |
Pulmonary embolism | 1 (1) | 0 (0) | 1 (0) |
Revision for infection | 1 (1) | 3 (2) | 4 (2) |
Revision for haematoma | 1 (1) | 0 (0) | 1 (0) |
Closed mobilisation | 0 (0) | 3 (2) | 3 (1) |
Opticusneuropathia | 0 (0) | 1 (1) | 1 (0) |
Myocardial infarction | 0 (0) | 1 (1) | 1 (0) |
Central vein thrombosis eye | 0 (0) | 1 (1) | 1 (0) |
Subcutaneous infection belly (related to DVT prophylaxis) | 0 (0) | 1 (1) | 1 (0) |
Total SAE | 5 (4) | 11 (9) | 16 (6) |